compounded glp-1 drugs New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our Yes You Can Medical |
Description
Application of liraglutide reduced mitochondrial damage by attenuating mitophagy via the protein phosphatase and tensin homolog-induced kinase 1 (PINK1)/Parkin pathway, the most well-known pathway for mitophagy (Figure 3)

Recuperato da: McIntyre RS, Mansur RB, Rosenblat JD, Kwan ATH

Eli Lilly) and others race to expand their cardiometabolic portfolios, innovative approaches that promise more effective weight loss or fewer side effects could set new therapies apart

however, upon reasonable request, additional analyses can be conducted after contact with the corresponding author
WangZVan FaassenMGroenHCantineauAVan OersAVan der VeenAet al
